Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerold S Harmatz

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Journal of Clinical Psychopharmacology|June 11, 2009
An irreverent look at the t testJerold S Harmatz
Clinical Pharmacology in Drug Development|May 4, 2016
Regression and CorrelationJerold S Harmatz, David J Greenblatt
British Journal of Clinical Pharmacology|April 30, 2015
Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studiesDavid J Greenblatt, Jerold S Harmatz
Journal of Clinical Pharmacology|March 29, 2007
Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2David J Greenblatt, Jerold S Harmatz, Aziz Karim
Journal of Clinical Psychopharmacology|April 3, 2019
Zolpidem and Gender: Are Women Really At Risk?David J Greenblatt, Jerold S Harmatz, Thomas Roth
Journal of Clinical Psychopharmacology|March 30, 2018
Vortioxetine Disposition in Obesity: Potential Implications for Patient SafetyDavid J Greenblatt, Jerold S Harmatz, Christina R Chow
Journal of Clinical Psychopharmacology|April 26, 2020
Diazepam in the Elderly: Looking Back, Ahead, and at the EvidenceDavid J Greenblatt, Jerold S Harmatz, Richard I Shader
Journal of Clinical Psychopharmacology|December 8, 2017
Update on Psychotropic Drug Prescribing in the United States: 2014-2015David J Greenblatt, Jerold S Harmatz, Richard I Shader
Journal of Clinical Psychopharmacology|December 31, 2010
Psychotropic drug prescribing in the United States: extent, costs, and expendituresDavid J Greenblatt, Jerold S Harmatz, Richard I Shader
British Journal of Clinical Pharmacology|August 27, 2005
Pharmocokinetics and pharmacodynamics of single-dose triazolam: electroencephalography compared with the Digit-Symbol Substitution TestDavid J Greenblatt, Lu Gan, Jerold S Harmatz, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Journal of Clinical Psychopharmacology|June 11, 2009
An irreverent look at the t testJerold S Harmatz
Clinical Pharmacology in Drug Development|May 4, 2016
Regression and CorrelationJerold S Harmatz, David J Greenblatt
British Journal of Clinical Pharmacology|April 30, 2015
Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studiesDavid J Greenblatt, Jerold S Harmatz
Journal of Clinical Pharmacology|March 29, 2007
Age and gender effects on the pharmacokinetics and pharmacodynamics of ramelteon, a hypnotic agent acting via melatonin receptors MT1 and MT2David J Greenblatt, Jerold S Harmatz, Aziz Karim
Journal of Clinical Psychopharmacology|April 3, 2019
Zolpidem and Gender: Are Women Really At Risk?David J Greenblatt, Jerold S Harmatz, Thomas Roth
Journal of Clinical Psychopharmacology|March 30, 2018
Vortioxetine Disposition in Obesity: Potential Implications for Patient SafetyDavid J Greenblatt, Jerold S Harmatz, Christina R Chow
Journal of Clinical Psychopharmacology|April 26, 2020
Diazepam in the Elderly: Looking Back, Ahead, and at the EvidenceDavid J Greenblatt, Jerold S Harmatz, Richard I Shader
Journal of Clinical Psychopharmacology|December 8, 2017
Update on Psychotropic Drug Prescribing in the United States: 2014-2015David J Greenblatt, Jerold S Harmatz, Richard I Shader
Journal of Clinical Psychopharmacology|December 31, 2010
Psychotropic drug prescribing in the United States: extent, costs, and expendituresDavid J Greenblatt, Jerold S Harmatz, Richard I Shader
British Journal of Clinical Pharmacology|August 27, 2005
Pharmocokinetics and pharmacodynamics of single-dose triazolam: electroencephalography compared with the Digit-Symbol Substitution TestDavid J Greenblatt, Lu Gan, Jerold S Harmatz, et al.
Pageof 7